Evolent Health Inc [NYSE: EVH] closed the trading session at $2280000.0 on 2025-06-23. The day’s price range saw the stock hit a low of $9.23, while the highest price level was $10.54.
The stocks have a year to date performance of -52.42 percent and weekly performance of 26.96 percent. The stock has been moved at -3.40 percent over the last six months. The stock has performed 31.25 percent around the most recent 30 days and changed 9.60 percent over the most recent 3-months.
If compared to the average trading volume of 2.28M shares, EVH reached to a volume of 11359945 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Evolent Health Inc [EVH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $15.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, BTIG Research dropped their target price from $36 to $29. The new note on the price target was released on December 03, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another drop from $38 to $16, while Stephens kept a Equal-Weight rating on EVH stock.
The Price to Book ratio for the last quarter was 1.30, with the Price to Cash per share for the same quarter was set at 2.24.
EVH stock trade performance evaluation
Evolent Health Inc [EVH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 26.96. With this latest performance, EVH shares gained by 31.25% in over the last four-week period, additionally sinking by -3.40% over the last 6 months – not to mention a drop of -6.67% in the past year of trading.
Evolent Health Inc [EVH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Evolent Health Inc [EVH] shares currently have an operating margin of -0.07% and a Gross Margin at 10.52%. Evolent Health Inc’s Net Margin is presently recorded at -5.86%.
Return on Equity for this stock declined to -4.11%, with Return on Assets sitting at -4.11%.
Earnings per share (EPS) analysis for Evolent Health Inc [EVH] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolent Health Inc go to 25.00%.
Evolent Health Inc [EVH]: Institutional Ownership
There are presently around $109.46%, or 111.03%% of EVH stock, in the hands of institutional investors. The top three institutional holders of EVH stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 11.17 million shares, which is approximately 9.7383%. VANGUARD GROUP INC, holding 11.06 million shares of the stock with an approximate value of $$211.39 million in EVH stocks shares; and VANGUARD GROUP INC, currently with $$166.1 million in EVH stock with ownership which is approximately 7.5745%.
